604 Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response

• Taha Merghoub,
• Sadna Budhu,
• Isabell Schulze,
• Lauren Dong,
• Hyejin Choi,
• Nezar Mehanna,
• Neal Rosen

Affiliations

Taha Merghoub

1Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Sadna Budhu

1MSKCC, New York, NY, USA

Isabell Schulze

1Memorial Sloan Kettering Cancer Center, New York, NY, USA

Lauren Dong

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Hyejin Choi

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Nezar Mehanna

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Neal Rosen

Memorial Sloan Kettering Cancer Center, New York, NY, USA